Levetiracetam +pharma (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action decreases neuronal excitability and limits the spread of abnormal electrical activity that leads to seizures.

The dosage of levetiracetam is individualized by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. The prescriber determines the appropriate starting dose and any necessary adjustments.

Levetiracetam’s pregnancy safety category is not definitively established. Clinicians weigh potential benefits against unknown risks when prescribing to pregnant or nursing women. Consultation with a healthcare professional is essential before use.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with older agents such as carbamazepine or phenytoin, levetiracetam has a simpler pharmacokinetic profile, fewer drug‑enzyme interactions, and is generally well tolerated. However, individual response varies, and clinicians choose therapy based on seizure type, comorbidities and patient-specific factors.

Levetiracetam tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture. Keep the product out of direct sunlight and away from excessive heat to maintain potency.

Levetiracetam is taken orally, usually as a tablet, with or without food. The exact dosing schedule—once, twice or three times daily—is determined by the prescriber based on therapeutic response and patient tolerance.

Serious risks include severe skin reactions (such as Stevens‑Johnson syndrome), mood disturbances including depression or suicidal thoughts, and rare blood disorders. Patients should be monitored for any new or worsening symptoms and seek medical attention promptly.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking interacting enzyme‑inducing medications.